EN
HI
Summary
As of 27 Aug, 2026, Amerise Biosciences stock price is ₹0.8. During the trading session, the stock has moved between an intraday low of ₹0.00 and an intraday high of ₹0.00. Over the last 52 weeks, Amerise Biosciences has traded between ₹0.50 and ₹1.03.
The stock has recorded a trading volume of 0 shares, with a market capitalization of ₹66069000. Its Average Traded Price (ATP) is ₹0.00, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 0 @ ₹0.80.
Amerise Biosciences has an upper circuit limit of ₹0.84 and a lower circuit limit of ₹0.76. The total value traded stands at ₹0.00, and the delivery percentage for the day is 100%.
The stock is currently traded with a market lot size of 1. Amerise Biosciences also offers a dividend yield of 0%.
Amerise Biosciences share price chart
Amerise Biosciences Share Key Metrics
Volume
0.00
Market Cap
5.29 CR
LTQ@LTP
0@0.80
ATP
0
Var Margin
100 %
Circuit Range
0.76-0.84
Delivery %
100 %
Value
0.00
ASM/GSM
No
Market Lot
1
Amerise Biosciences Fundamentals
P/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
35.26
Sector P/B
1.4
Sec. Div. Yield
0.41
Amerise Biosciences Resistance and Support
Pivot 0.81
Resistance
First Resistance
0.82
Second Resistance
0.83
Third Resistance
0.84
Support
First Support
0.8
Second Support
0.79
Third Support
0.78
Amerise Biosciences Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Wed Aug 26 2026 | 0.81 | 0.8 | -2.44% | 0.81 | 0.8 |
| Tue Aug 25 2026 | 0.83 | 0.82 | -1.20% | 0.83 | 0.82 |
| Mon Aug 24 2026 | 0.82 | 0.83 | 1.22% | 0.83 | 0.82 |
Amerise Biosciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-03 | Quarterly Results |
| 2026-05-05 | Audited Results |
| 2026-02-02 | Quarterly Results |
| 2025-11-05 | Quarterly Results |
| 2025-07-24 | Quarterly Results |
| 2025-05-19 | Audited Results |
| 2025-02-03 | Quarterly Results & Others |
| 2024-10-22 | Quarterly Results |
| 2024-08-06 | Quarterly Results |
Amerise Biosciences News
Amerise Biosciences Ltd - 531681 - Board Meeting Outcome for Outcome Of Board Meeting Held On 3Rd August 2026
Amerise Biosciences board approved Q1 FY27 standalone financial results. The company reported a total income of ₹7.92 lakhs and a net loss of ₹8.14 lakhs for the quarter ended June 30, 2026, with basic EPS at -₹0.01.
Aug 03 2026 17:22:14
Amerise Biosciences Management
| Name | Position |
|---|---|
| Kelash Bunkar | Non Executive Independent Director |
| Manisha Patel | Non Executive Independent Director |
Amerise Biosciences Similar Stocks
Thirani Projects Ltd.
3.24
0.00 (0.00%)
KLG Capital Services Ltd.
0.00
0.00 (0.00%)
Inditrade Capital Ltd.
2.77
0.00 (0.00%)
Williamson Financial Services Ltd.
4.34
0.00 (0.00%)
Kinetic Trust Ltd.
61.98
0.00 (0.00%)
Explicit Finance Ltd.
7.61
0.00 (0.00%)
Ganesh Holdings Ltd.
100.70
0.00 (0.00%)
Peoples Investments Ltd.
235.80
0.00 (0.00%)
Wagend Infra Venture Ltd.
1.25
0.00 (0.00%)
Mid East Portfolio Management Ltd.
34.50
0.00 (0.00%)
Amerise Biosciences FAQs
The Buying Price of Amerise Biosciences share is 0.8 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Amerise Biosciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Amerise Biosciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Amerise Biosciences shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Amerise Biosciences shares is 0. Useful to assess the stock's value relative to its book value.
To assess Amerise Biosciences’s valuation compare Sector P/E, P/B which are 35.26 & 1.4 with sector averages, along with growth rates and financial metrics.
The Market Cap of Amerise Biosciences is 5.29 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Amerise Biosciences share price is 1.03 & 0.50. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Amerise Biosciences belongs to the Finance sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
